These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
317 related items for PubMed ID: 17667051
21. Breath tests in the diagnosis of small intestinal bacterial overgrowth in patients with irritable bowel syndrome in comparison with quantitative upper gut aspirate culture. Ghoshal UC, Srivastava D, Ghoshal U, Misra A. Eur J Gastroenterol Hepatol; 2014 Jul; 26(7):753-60. PubMed ID: 24849768 [Abstract] [Full Text] [Related]
27. [Estimation of small intestinal bacterial overgrowth in patients with constipation and diarrhea irritable bowel syndrome]. Łokieć K, Klupińska G, Walecka-Kapica E, Błońska A. Pol Merkur Lekarski; 2014 May; 36(215):307-10. PubMed ID: 24964506 [Abstract] [Full Text] [Related]
28. T-cell activation in patients with irritable bowel syndrome. Ohman L, Isaksson S, Lindmark AC, Posserud I, Stotzer PO, Strid H, Sjövall H, Simrén M. Am J Gastroenterol; 2009 May; 104(5):1205-12. PubMed ID: 19367268 [Abstract] [Full Text] [Related]
31. Isolation of murine small intestinal intraepithelial γδt cells. Ye Y, Yue M, Jin X, Chen S, Li Y. Immunol Invest; 2010 May; 39(7):661-73. PubMed ID: 20840053 [Abstract] [Full Text] [Related]
35. Role of routine small intestinal biopsy in adult patient with irritable bowel syndrome-like symptoms. Pironti A, Tadeu V, Pedroni A, Porcu A, Manca A, Massarelli G, Realdi G, Dore MP. Minerva Med; 2010 Jun; 101(3):129-34. PubMed ID: 20562801 [Abstract] [Full Text] [Related]
36. Peppermint oil (Mintoil) in the treatment of irritable bowel syndrome: a prospective double blind placebo-controlled randomized trial. Cappello G, Spezzaferro M, Grossi L, Manzoli L, Marzio L. Dig Liver Dis; 2007 Jun; 39(6):530-6. PubMed ID: 17420159 [Abstract] [Full Text] [Related]
37. Flow cytometric determination of aberrant intra-epithelial lymphocytes predicts T-cell lymphoma development more accurately than T-cell clonality analysis in Refractory Celiac Disease. Verbeek WH, Goerres MS, von Blomberg BM, Oudejans JJ, Scholten PE, Hadithi M, Al-Toma A, Schreurs MW, Mulder CJ. Clin Immunol; 2008 Jan; 126(1):48-56. PubMed ID: 18024205 [Abstract] [Full Text] [Related]
38. Duodenal and rectal mucosal microbiota related to small intestinal bacterial overgrowth in diarrhea-predominant irritable bowel syndrome. Yang M, Zhang L, Hong G, Li Y, Li G, Qian W, Xiong H, Bai T, Song J, Hou X. J Gastroenterol Hepatol; 2020 May; 35(5):795-805. PubMed ID: 31674052 [Abstract] [Full Text] [Related]
39. Lack of intestinal mucosal toxicity of Triticum monococcum in celiac disease patients. Pizzuti D, Buda A, D'Odorico A, D'Incà R, Chiarelli S, Curioni A, Martines D. Scand J Gastroenterol; 2006 Nov; 41(11):1305-11. PubMed ID: 17060124 [Abstract] [Full Text] [Related]
40. Small intestinal bacterial overgrowth in patients with irritable bowel syndrome. Posserud I, Stotzer PO, Björnsson ES, Abrahamsson H, Simrén M. Gut; 2007 Jun; 56(6):802-8. PubMed ID: 17148502 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]